about
Neuroprotection for treatment of glaucoma in adultsNeuroprotection for treatment of glaucoma in adultsNeuroprotection for treatment of glaucoma in adults.The role of scanning laser polarimetry using the GDx variable corneal compensator in the management of glaucoma suspectsNew directions in the treatment of normal tension glaucoma.Combining structural and functional measurements to improve detection of glaucoma progression using Bayesian hierarchical modelsLongitudinal relationship between retinal nerve fiber layer thickness parameters assessed by scanning laser polarimetry (GDxVCC) and visual field in glaucoma.Portsmouth visual field database: an audit of glaucoma progressionCombining structural and functional measurements to improve estimates of rates of glaucomatous progression.Definition of glaucoma: clinical and experimental concepts.Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma.Normal-tension glaucoma (Low-tension glaucoma)Glaucoma diagnostics.Detecting the progression of normal tension glaucoma: a comparison of perimetry, optic coherence tomography, and Heidelberg retinal tomography.Comparison of clinical characteristics and progression rates of bilaterally and unilaterally progressing glaucomaDifferences in corneal parameters between normal tension glaucoma and primary open-angle glaucoma.Incorporating life expectancy in glaucoma care.Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma.Characteristics of patients with primary open angle glaucoma and normal tension glaucoma at a university hospital: a cross-sectional retrospective studyNew paradigms in the mechanisms and management of glaucoma.Long Term Results of Visual Field Progression Analysis in Open Angle Glaucoma Patients Under TreatmentSQSTM1 Mutations and Glaucoma.Eyes with Suspicious Appearance of the Optic Disc and Normal Intraocular Pressure: Using Clinical and Epidemiological Characteristics to Differentiate Those with and without Glaucoma.Biomechanical assessment in models of glaucomatous optic neuropathy.Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma.Glaucoma management in Sweden -- results from a nationwide survey.Practical recommendations for measuring rates of visual field change in glaucoma.Rates of visual field progression in clinical glaucoma careCorneal hysteresis as a risk factor for glaucoma progression: a prospective longitudinal study.Improved prediction of rates of visual field loss in glaucoma using empirical Bayes estimates of slopes of changeIncorporating risk factors to improve the assessment of rates of glaucomatous progression.The medical and surgical treatment of glaucoma.Differential Association of Metabolic Risk Factors with Open Angle Glaucoma according to Obesity in a Korean Population.Initial central scotomas vs peripheral scotomas in normal-tension glaucoma: clinical characteristics and progression ratesRole of cerebrospinal fluid pressure in the pathogenesis of glaucoma.A review of current technology used in evaluating visual function in glaucoma.Perimetry, tonometry and epidemiology: the fate of glaucoma management.Combining structure and function to evaluate glaucomatous progression: implications for the design of clinical trials.Clinical update on normal tension glaucoma.The risk of newly developed visual impairment in treated normal-tension glaucoma: 10-year follow-up.
P2860
Q24200657-B039902F-2D02-446D-BF8F-7D36D09E8958Q24240024-02D5643E-1D11-4B1A-8013-709233D6DEA5Q30238789-B0BD116A-8C29-4D84-93E7-DEFC47CED9F3Q33252653-67FC73F1-BD6D-42A3-9D9E-48D239723405Q33785942-1D5C2C7E-BAA6-4E37-A88B-AC093636A81FQ33938838-E5366AFA-617F-4EEA-A4D0-D72B458BB625Q34041177-E759FF5E-1501-42B0-BC2E-1E982C628DBDQ34055002-96C5A4BD-D764-4050-A51D-56702171BBB5Q34154000-02C5677A-2A0A-4591-B8F1-AB51CD6EDF44Q34256241-708D1A9F-642D-4E3E-AA07-1493335D47A2Q34263078-E39B9426-BE56-4B9A-99E1-2F5ABC28407EQ34571907-05EB6D1B-7B61-4E10-BEFA-F6D4D72E18F4Q34577535-91276F46-2092-4927-B157-085B63623AD3Q35024539-ADAA8489-5216-41A1-8CE1-8AE2644FDB45Q35024544-66F41CBD-4530-45C9-9B78-7DE599880EDCQ35447773-1674667C-0F0C-438B-9750-766B6DF10A00Q35603517-A2300F7A-1F7B-49F3-AB54-5EE190680544Q35681331-DD82DEB3-F9B8-4005-9B24-DAC8E46DDEE5Q35749323-7EE41C5C-1EE7-4201-AA19-4039D5E362D2Q35949074-DA54902E-25D4-490F-ABE7-843ED628F8F2Q35970005-AE2724EF-40BA-4B24-AC7F-5E2B0F74AA75Q36044818-7ED533BF-7703-47F0-8CCC-E8092966B8FAQ36081507-720B0AAB-3049-4C58-BEB7-9F15740F144AQ36236749-AC7AA934-64B1-4243-A5BF-5BDDB5A988C5Q36515582-24F87FD7-2FA8-4C17-9863-32A040D45467Q36629158-83147CB0-713F-4C27-9731-EEC339611BCAQ37062593-AE550366-AB2B-4A3F-9476-C0242027C09AQ37233278-DAA5D8D9-6AB4-4584-86FC-8AB5BCF673CFQ37244612-9AF8CAEA-8EE8-4A8C-B3FA-7F71270758DBQ37244726-E79EA99C-F240-4C6B-A093-A2D19553A61CQ37255015-D209BD56-17FA-4EAA-8C1C-9FABC377F2AAQ37405146-52FF0A1F-6C06-410C-8E4C-18199630EB99Q37526064-BD3C9996-2D75-4591-B0DB-5CAC5DADE35FQ37663234-22DB4A56-5F39-4613-83AE-DD16B052FF5CQ37747751-5CE685D3-18D2-40AC-8203-5451C754EB2FQ37810943-C686B3A7-D149-41AC-847A-DBEAAE75EFF7Q37880251-754B79D5-933F-415E-A5C9-4DE558FDE602Q38065532-EED8EC9A-91D8-402E-B076-03C0D9193F62Q38108640-CBFAC7EC-32B6-4B59-99E1-28264ACFB0E3Q38201842-D18A1379-30B7-429E-8FD5-4B60A0D581DB
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Natural history of normal-tension glaucoma.
@en
Natural history of normal-tension glaucoma.
@nl
type
label
Natural history of normal-tension glaucoma.
@en
Natural history of normal-tension glaucoma.
@nl
prefLabel
Natural history of normal-tension glaucoma.
@en
Natural history of normal-tension glaucoma.
@nl
P2093
P1433
P1476
Natural history of normal-tension glaucoma.
@en
P2093
Collaborative Normal-Tension Glaucoma Study Group
D R Anderson
M Schulzer
S M Drance
P304
P356
10.1016/S0161-6420(00)00518-2
P577
2001-02-01T00:00:00Z